{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:25Z","timestamp":1786980145969,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00417-024-06660-1","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T22:52:49Z","timestamp":1731624769000},"page":"679-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy"],"prefix":"10.1007","volume":"263","author":[{"given":"Melissa","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itika","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine Millner","family":"Overbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cade","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Ploumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Lains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Vingopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-9738","authenticated-orcid":false,"given":"John B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"6660_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124\u2013136. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3","journal-title":"Lancet"},{"key":"6660_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham Y-C, Yu M et al (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology 128:1580\u20131591. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"key":"6660_CR3","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677\u20131682. https:\/\/doi.org\/10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"key":"6660_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006982-198101020-00010","volume":"1","author":"D Finkelstein","year":"1981","unstructured":"Finkelstein D, Patz A, Fine SL et al (1981) Abortive foveal retinal neovascularization in diabetic retinopathy. Retina 1:62\u201366","journal-title":"Retina"},{"key":"6660_CR5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1001\/archopht.1987.01060120070027","volume":"105","author":"BC Joondeph","year":"1987","unstructured":"Joondeph BC, Joondeph HC, Flood TP (1987) Foveal Neovascularization in Diabetic Retinopathy. Arch Ophthalmol 105:1672\u20131675. https:\/\/doi.org\/10.1001\/archopht.1987.01060120070027","journal-title":"Arch Ophthalmol"},{"key":"6660_CR6","doi-asserted-by":"publisher","unstructured":"Murakawa S, Hasegawa T, Koizumi H, Maruko I, Iida T (2017) Foveal retinal neovascularization in proliferative diabetic retinopathy: Assessment by optical coherence tomography angiography. Retina 37:e135\u2013e137. https:\/\/doi.org\/10.1097\/IAE.0000000000001880","DOI":"10.1097\/IAE.0000000000001880"},{"key":"6660_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10792-009-9317-8","volume":"30","author":"J Rajagopal","year":"2010","unstructured":"Rajagopal J, Kamath AG, Kamath GG, Solanki N (2010) Foveal neovascularisation in diabetic retinopathy: case report and review of literature. Int Ophthalmol 30:311\u2013314. https:\/\/doi.org\/10.1007\/s10792-009-9317-8","journal-title":"Int Ophthalmol"},{"key":"6660_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK et al (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1\u201355. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.11.003","journal-title":"Prog Retin Eye Res"},{"key":"6660_CR9","doi-asserted-by":"publisher","first-page":"100951","DOI":"10.1016\/j.preteyeres.2021.100951","volume":"84","author":"I La\u00edns","year":"2021","unstructured":"La\u00edns I, Wang JC, Cui Y et al (2021) Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Prog Retin Eye Res 84:100951. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100951","journal-title":"Prog Retin Eye Res"},{"key":"6660_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000516525","volume":"244","author":"A Kilani","year":"2021","unstructured":"Kilani A, Werner JU, Lang GK, Lang GE (2021) Optical coherence tomography angiography findings in proliferative diabetic retinopathy. Ophthalmologica 244:258\u2013264. https:\/\/doi.org\/10.1159\/000516525","journal-title":"Ophthalmologica"},{"key":"6660_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000485831","volume":"9","author":"K Andreanos","year":"2018","unstructured":"Andreanos K, Rotsos T, Kymionis G et al (2018) Optical coherence tomography angiography of foveal neovascularization in diabetic retinopathy. Case Rep Ophthalmol 9:93\u201397. https:\/\/doi.org\/10.1159\/000485831","journal-title":"Case Rep Ophthalmol"},{"key":"6660_CR12","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1177\/11206721221075900","volume":"32","author":"R Venkatesh","year":"2022","unstructured":"Venkatesh R, Reddy NG, Jayadev C et al (2022) Contributory factors for developing foveal neovascularization in proliferative diabetic retinopathy. Eur J Ophthalmol 32:3615\u20133621. https:\/\/doi.org\/10.1177\/11206721221075900","journal-title":"Eur J Ophthalmol"},{"key":"6660_CR13","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.ajoc.2022.101435","volume":"26","author":"T Hirano","year":"2022","unstructured":"Hirano T, Takahashi Y, Hoshiyama K, Murata T (2022) Optical coherence tomography angiography findings before and after onset of foveal retinal neovascularization in diabetic retinopathy. Am J Ophthalmol Case Rep 26:101435. https:\/\/doi.org\/10.1016\/j.ajoc.2022.101435","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6660_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.oret.2019.03.004","volume":"3","author":"S Vaz-Pereira","year":"2019","unstructured":"Vaz-Pereira S, Proen\u00e7a H (2019) Foveal neovascularization in type 2 diabetes. Oph Retina 3:566. https:\/\/doi.org\/10.1016\/j.oret.2019.03.004","journal-title":"Oph Retina"},{"key":"6660_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/ojo.OJO_64_2015","volume":"10","author":"A Seth","year":"2017","unstructured":"Seth A, Ghosh B, Bhambhwani V et al (2017) Foveal neovascularization in a patient with Type 2 diabetes mellitus. Oman J Ophthalmol 10:255. https:\/\/doi.org\/10.4103\/ojo.OJO_64_2015","journal-title":"Oman J Ophthalmol"},{"key":"6660_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/B:INTE.0000031744.93778.60","volume":"25","author":"LS Schocket","year":"2004","unstructured":"Schocket LS, Brucker AJ, Niknam RM et al (2004) Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol 25:89\u201394. https:\/\/doi.org\/10.1023\/B:INTE.0000031744.93778.60","journal-title":"Int Ophthalmol"},{"key":"6660_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","volume":"132","author":"JK Sun","year":"2014","unstructured":"Sun JK, Lin MM, Lammer J et al (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132:1309\u20131316. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2350","journal-title":"JAMA Ophthalmol"},{"key":"6660_CR18","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2019.5790","volume":"321","author":"CW Baker","year":"2019","unstructured":"Baker CW, Glassman AR, Beaulieu WT et al (2019) Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity. JAMA 321:1880\u20131894. https:\/\/doi.org\/10.1001\/jama.2019.5790","journal-title":"JAMA"},{"key":"6660_CR19","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1167\/iovs.10-6024","volume":"52","author":"W Rahman","year":"2011","unstructured":"Rahman W, Chen FK, Yeoh J et al (2011) Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 52:2267\u20132271. https:\/\/doi.org\/10.1167\/iovs.10-6024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6660_CR20","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/aos.14189","volume":"98","author":"SY Moon","year":"2020","unstructured":"Moon SY, Park SP, Kim Y-K (2020) Evaluation of posterior vitreous detachment using ultrasonography and optical coherence tomography. Acta Ophthalmol 98:e29\u2013e35. https:\/\/doi.org\/10.1111\/aos.14189","journal-title":"Acta Ophthalmol"},{"key":"6660_CR21","doi-asserted-by":"publisher","first-page":"100144","DOI":"10.1016\/j.xops.2022.100144","volume":"2","author":"I Garg","year":"2022","unstructured":"Garg I, Uwakwe C, Le R et al (2022) Nonperfusion area and other vascular metrics by wider field swept-source oct angiography as biomarkers of diabetic retinopathy severity. Ophthalmol Sci 2:100144. https:\/\/doi.org\/10.1016\/j.xops.2022.100144","journal-title":"Ophthalmol Sci"},{"key":"6660_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"6660_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ajo.2020.08.045","volume":"222","author":"Z Chu","year":"2021","unstructured":"Chu Z, Zhang Q, Gregori G et al (2021) Guidelines for imaging the choriocapillaris using OCT angiography. Am J Ophthalmol 222:92\u2013101. https:\/\/doi.org\/10.1016\/j.ajo.2020.08.045","journal-title":"Am J Ophthalmol"},{"key":"6660_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000027411","volume":"213","author":"T Ishibashi","year":"1999","unstructured":"Ishibashi T, Murata T, Kohno T et al (1999) Peripheral choriovitreal neovascularization in proliferative diabetic retinopathy: histopathologic and ultrastructural study. Ophthalmologica 213:154\u2013158. https:\/\/doi.org\/10.1159\/000027411","journal-title":"Ophthalmologica"},{"key":"6660_CR25","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.ajoc.2021.101199","volume":"24","author":"F Romano","year":"2021","unstructured":"Romano F, Preziosa C, Staurenghi G, Pellegrini M (2021) Foveal neovascularization in combined branch retinal vein and artery occlusion. Am J Ophthalmol Case Rep 24:101199. https:\/\/doi.org\/10.1016\/j.ajoc.2021.101199","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6660_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/IAE.0000000000001336","volume":"37","author":"S Vaz-Pereira","year":"2017","unstructured":"Vaz-Pereira S, Dansingani KK, Chen KC et al (2017) Tomographic relationships between retinal neovascularization and the posterior vitreous in proliferative diabetic retinopathy. Retina 37:1287. https:\/\/doi.org\/10.1097\/IAE.0000000000001336","journal-title":"Retina"},{"key":"6660_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10792-005-5389-2","volume":"26","author":"R Ono","year":"2005","unstructured":"Ono R, Kakehashi A, Yamagami H et al (2005) Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment. Int Ophthalmol 26:15\u201319. https:\/\/doi.org\/10.1007\/s10792-005-5389-2","journal-title":"Int Ophthalmol"},{"key":"6660_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00417-016-3360-8","volume":"254","author":"D Melancia","year":"2016","unstructured":"Melancia D, Vicente A, Cunha JP et al (2016) Diabetic choroidopathy: a review of the current literature. Graefes Arch Clin Exp Ophthalmol 254:1453\u20131461. https:\/\/doi.org\/10.1007\/s00417-016-3360-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6660_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/08820538.2022.2109939","volume":"38","author":"RB Singh","year":"2023","unstructured":"Singh RB, Perepelkina T, Testi I et al (2023) Imaging-based assessment of choriocapillaris: A comprehensive review. Semin Ophthalmol 38:405\u2013426. https:\/\/doi.org\/10.1080\/08820538.2022.2109939","journal-title":"Semin Ophthalmol"},{"key":"6660_CR30","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.3390\/ijms241210167","volume":"24","author":"L Scuderi","year":"2023","unstructured":"Scuderi L, Fragiotta S, Di Pippo M, Abdolrahimzadeh S (2023) The role of diabetic choroidopathy in the pathogenesis and progression of diabetic retinopathy. Int J Mol Sci 24:10167. https:\/\/doi.org\/10.3390\/ijms241210167","journal-title":"Int J Mol Sci"},{"key":"6660_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajo.2017.09.030","volume":"184","author":"JC Wang","year":"2017","unstructured":"Wang JC, La\u00edns I, Provid\u00eancia J et al (2017) Diabetic choroidopathy: choroidal vascular density and volume in diabetic retinopathy with swept-source optical coherence tomography. Am J Ophthalmol 184:75\u201383. https:\/\/doi.org\/10.1016\/j.ajo.2017.09.030","journal-title":"Am J Ophthalmol"},{"issue":"Pt 6","key":"6660_CR32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/eye.1997.224","volume":"11","author":"R Zylbermann","year":"1997","unstructured":"Zylbermann R, Landau D, Rozenman Y et al (1997) Exudative age-related macular degeneration in patients with diabetic retinopathy and its relation to retinal laser photocoagulation. Eye (Lond) 11(Pt 6):872\u2013875. https:\/\/doi.org\/10.1038\/eye.1997.224","journal-title":"Eye (Lond)"},{"key":"6660_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1120672120902027","volume":"31","author":"SR Singh","year":"2021","unstructured":"Singh SR, Parameswarappa DC, Govindahari V et al (2021) Clinical and angiographic characterization of choroidal neovascularization in diabetic retinopathy. Eur J Ophthalmol 31:584\u2013591. https:\/\/doi.org\/10.1177\/1120672120902027","journal-title":"Eur J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06660-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T15:26:22Z","timestamp":1743348382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06660-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6660"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06660-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JBM is a consultant for Alcon, Allergan, Carl Zeiss, Sunovion, Topcon, and Genentech. DGV has been an advisor to\u00a0Drusolv; is an inventor on patents of Neuroprotection held by Mass Eye and Ear. DH is a consultant for Allergan,\u00a0Genetech, Omeicos Therapeutics, and has received financial support from National Eye Institute, Lions VisionGift,\u00a0Commonwealth Grant, Lions International and the Macula Society. JWM is consultant for Genetech\/Roche, Sunovion,\u00a0KalVista Pharmaceuticals, ONL Therapeutics; has received financial support from Heidelberg Engineering, Lowy\u00a0Medical Research Institute, Ltd.; is an inventor of patent - US 7,811,832 (with royalties paid by ONL Therapeutics to\u00a0Massachusetts Eye and Ear), US 5,798,349, US 6,225,303, US 6,610,679, CA 2,185,644, CA 2,536,069 (with royalties\u00a0paid by Valeant Pharmaceuticals to Massachusetts Eye and Ear). LAK is a consultant for Ingenia Therapeutics,\u00a0CureVac AG, Pykus Therapeutics, and has received grant support from the National Eye Institute and the Department\u00a0of Defense. NAP is a consultant for Regeneron, Dutch Ophthalmic, Genentech, EyePoint Pharmaceuticals, Alcon\u00a0Vision.\u00a0MY, FR, XD, MG, IG, KMO, CFB, IP, IS, IL, FV, and JR have no relevant financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}